Zacks Analyst Blog Highlights: NVIDIA Corporation, Chevron Corporation and Accenture plc

0

For immediate release

Chicago, IL – January 21, 2022 – Zacks.com announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: NVIDIA Corporation NVDA, Chevron Corporation CVX and Accenture plc ACN.

Here are highlights from Thursday’s analyst blog:

Best Stock Reports for NVIDIA, Chevron and Accenture

Zacks Research Daily features top research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Chevron Corporation (CLC) and Accenture plc (ACN). These research reports have been handpicked from the approximately 70 reports published today by our team of analysts.

You can see all today’s research reports here >>>

Shares of Nvidia have massively outperformed the Zacks General Semiconductor industry over the past year (+80.9% vs. +33.3%) thanks to the chipmaker’s influence on all major emerging trends in the tech space broader, ranging from artificial intelligence to analytics and games. The company is also considered a major player in the AR/VR space and stands to benefit from developments on the metaverse front.

The increase in Hyperscale demand remains a tailwind for NVIDIA’s Data Center business. The expansion of NVIDIA GeForce NOW should boost the user base. The collaboration with Mercedes-Benz should further strengthen NVIDIA’s presence in the field of autonomous vehicles. A strong lineup of advanced graphics cards has made it a preferred graphics card vendor for PC makers.

(You can read the full NVIDIA research report here >>>)

Chevron shares have gained +16.7% over the past three months against the industry Zacks Integrated Oil’s +9.2% gain. The Zacks analyst believes Chevron appears to be one of the best positioned global integrated oil companies to achieve a sustained production ramp-up. The company’s average production in the first nine months of 2021 was 3,093,000 barrels of oil equivalent per day.

Chevron acquired Noble Energy for $5 billion, which expanded its presence in the DJ Basin and Permian Basin. CVX’s existing project pipeline is among the best in the industry, thanks to its prominent position in the lucrative Permian Basin. Chevron, however, was forced to drastically cut spending due to falling prices last year. High oil price sensitivity is another major concern.

(You can read the full Chevron research report here >>>)

Shares of Accenture gained +10.2% over the past three months vs. Zacks Consulting’s sector gain of +9.9%. The Zacks analyst believes Accenture has been gaining traction in its outsourcing and consulting businesses due to strong demand for services that not only improve operational efficiency but also reduce costs.

ACN has also made strides toward improving its cloud and digital marketing suite through buyouts and partnerships. Strong operating cash flow has helped it reward shareholders through dividend payments and stock buybacks. Pricing pressure, foreign currency fluctuations and integration risks related to takeovers continue to weigh on its margins.

(You can read the full Accenture research report here >>>)

Other noteworthy reports we feature today include American Express Co. (AXP) and HCA Healthcare, Inc. (HCA).

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

As one investor put it, “curing and preventing hundreds of diseases…what should this market be worth?” This company could rival or surpass other recent Zacks stocks that are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in a year.

Free: See our best stock and our 4 finalists >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

https://www.zacks.com

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.

5 shares ready to double

Each has been handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have skyrocketed +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report fly under the radar on Wall Street, which provides a great opportunity to get in on the ground floor.

Today, check out these 5 potential home runs >>

Click to get this free report

Accenture PLC (ACN): Free Inventory Analysis Report

Chevron Corporation (CVX): Free Stock Analysis Report

NVIDIA Corporation (NVDA): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Share.

Comments are closed.